Literature DB >> 16937450

Role of detection of microsatellite instability in Chinese with hereditary nonpolyposis colorectal cancer or ordinary hereditary colorectal cancer.

Wen-Zhi Liu1, Feng Jin, Zhen-Hai Zhang, Shu-Bao Wang.   

Abstract

AIM: To detect microsatellite instability (MSI) in patients with hereditary nonpolyposis colorectal cancer or ordinary hereditary colorectal cancer and to provide criteria for screening the kindreds with hereditary nonpolyposis colorectal cancer at molecular level.
METHODS: MSI was detected in the specimens from 20 cases with HNPCC, 20 cases with ordinary hereditary colorectal cancer and 20 cases with sporadic colorectal cancer by means of polymerase chain reaction-single strand conformation polymorphism.
RESULTS: The positive rate of MSI was 85% (17/20) in HNPCC group, 40% (8/20) in ordinary hereditary colorectal cancer group and 10% (2/20) in the sporadic colorectal cancer group respectively. The differences were significant. The mean ages of the three groups were 43.6, 52.2, and 61.8 years respectively, which increased gradually. The incidence of right hemicolon cancer was 64.7%, 37.5%, and 0% respectively, which decreased gradually and had significant difference. The expression ratio of BAT26 and BAT25 was 94.1% respectively, which was highest in the 5 gene sites studied. The incidence of poorly differentiated adenocarcinoma was 70.6% in HNPCC group among high frequency microsatellite instability (MSI-H), which was higher than the other two groups, which had 50% and 50% respectively.
CONCLUSION: The incidence of MSI-H is higher in HNPCC group. The detection of MSI is simple and economical and has high correlation with the clinicopathologic feature of HNPCC and can be used as a screening method to detect the germ line mutation of the mismatch repair gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937450      PMCID: PMC4087844          DOI: 10.3748/wjg.v12.i29.4745

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  Heritable colorectal cancer syndromes: recognition and preventive management.

Authors:  Lisa A Boardman
Journal:  Gastroenterol Clin North Am       Date:  2002-12       Impact factor: 3.806

2.  Colorectal carcinomas with high microsatellite instability: defining a distinct immunologic and molecular entity with respect to prognostic markers.

Authors:  T B Edmonston; K H Cuesta; S Burkholder; A Barusevicius; D Rose; A J Kovatich; B Boman; R Fry; R Fishel; J P Palazzo
Journal:  Hum Pathol       Date:  2000-12       Impact factor: 3.466

3.  Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer.

Authors:  T Debniak; G Kurzawski; B Gorski; J Kladny; W Domagala; J Lubinski
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

Review 4.  Hereditary nonpolyposis colorectal cancer.

Authors:  H T Lynch; J F Lynch
Journal:  Semin Surg Oncol       Date:  2000-06

5.  Optimising methods for determining RER status in colorectal cancers.

Authors:  J G Stone; I P Tomlinson; R S Houlston
Journal:  Cancer Lett       Date:  2000-02-28       Impact factor: 8.679

6.  Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.

Authors:  J P Terdiman; J R Gum; P G Conrad; G A Miller; V Weinberg; S C Crawley; T R Levin; C Reeves; A Schmitt; M Hepburn; M H Sleisenger; Y S Kim
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

7.  Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer.

Authors:  T Liu; S Wahlberg; E Burek; P Lindblom; C Rubio; A Lindblom
Journal:  Genes Chromosomes Cancer       Date:  2000-01       Impact factor: 5.006

8.  Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.

Authors:  A Hemminki; J P Mecklin; H Järvinen; L A Aaltonen; H Joensuu
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

9.  Lynch syndrome: genetics, natural history, genetic counseling, and prevention.

Authors:  H T Lynch; J Lynch
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

Review 10.  Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC).

Authors:  Annegret Müller; Richard Fishel
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

View more
  1 in total

Review 1.  Advances in the study of Lynch syndrome in China.

Authors:  Jun-Yu Lu; Jian-Qiu Sheng
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.